Feng Zhao
Sir Run Run Shaw Hospital(CN)Zhejiang Cancer Hospital(CN)First Affiliated Hospital Zhejiang University(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Advanced Radiotherapy Techniques, Liver Disease Diagnosis and Treatment, Prostate Cancer Treatment and Research, Cancer-related gene regulation
Most-Cited Works
- → PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib(2007)717 cited
- → Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer(2018)409 cited
- → Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas(2016)218 cited
- → Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes(2011)163 cited
- → An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition(2016)162 cited